PT1720832E - Processo de preparação de derivados de 4-cetoprolina n-protegidos - Google Patents
Processo de preparação de derivados de 4-cetoprolina n-protegidosInfo
- Publication number
- PT1720832E PT1720832E PT57075343T PT05707534T PT1720832E PT 1720832 E PT1720832 E PT 1720832E PT 57075343 T PT57075343 T PT 57075343T PT 05707534 T PT05707534 T PT 05707534T PT 1720832 E PT1720832 E PT 1720832E
- Authority
- PT
- Portugal
- Prior art keywords
- protected
- preparing
- ketoproline
- derivatives
- ketoproline derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004010943A DE102004010943A1 (de) | 2004-03-03 | 2004-03-03 | Verfahren zur Herstellung von N-geschützten 4-Ketprolinderivaten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1720832E true PT1720832E (pt) | 2013-03-04 |
Family
ID=34894987
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT57075343T PT1720832E (pt) | 2004-03-03 | 2005-02-19 | Processo de preparação de derivados de 4-cetoprolina n-protegidos |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8618310B2 (pt) |
| EP (1) | EP1720832B1 (pt) |
| JP (1) | JP4728317B2 (pt) |
| CN (1) | CN1926102B (pt) |
| CA (1) | CA2557017C (pt) |
| DE (1) | DE102004010943A1 (pt) |
| PT (1) | PT1720832E (pt) |
| WO (1) | WO2005095340A1 (pt) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0819097D0 (en) * | 2008-10-17 | 2008-11-26 | Spirogen Ltd | Pyrrolobenzodiazepines |
| US8697688B2 (en) | 2010-04-15 | 2014-04-15 | Seattle Genetics Inc. | Pyrrolobenzodiazepines used to treat proliferative diseases |
| WO2011130613A1 (en) | 2010-04-15 | 2011-10-20 | Seattle Genetics, Inc. | Targeted pyrrolobenzodiazapine conjugates |
| AU2012311505B2 (en) | 2011-09-20 | 2016-09-29 | Medimmune Limited | Pyrrolobenzodiazepines as unsymmetrical dimeric PBD compounds for inclusion in targeted conjugates |
| AU2012322613B2 (en) | 2011-10-14 | 2016-04-21 | Medimmune Limited | Pyrrolobenzodiazepines and targeted conjugates |
| CN108164551A (zh) | 2011-10-14 | 2018-06-15 | 西雅图基因公司 | 吡咯并苯并二氮杂卓和靶向结合物 |
| US9388187B2 (en) | 2011-10-14 | 2016-07-12 | Medimmune Limited | Pyrrolobenzodiazepines |
| AU2012322934B2 (en) | 2011-10-14 | 2016-09-08 | Medimmune Limited | Pyrrolobenzodiazepines |
| NZ707543A (en) | 2012-10-12 | 2018-09-28 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates |
| ES2680153T3 (es) | 2012-10-12 | 2018-09-04 | Adc Therapeutics Sa | Conjugados de anticuerpos anti-PSMA-pirrolobenzodiazepinas |
| AU2013328623B8 (en) | 2012-10-12 | 2017-06-15 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates |
| SI2906253T1 (sl) | 2012-10-12 | 2018-11-30 | Adc Therapeutics Sa | Konjugati pirolobenzodiazepin-protitelo proti PSMA |
| ES2530968T3 (es) | 2012-10-12 | 2015-03-09 | Spirogen Sarl | Pirrolobenzodiazepinas y conjugados de las mismas |
| CA2885305C (en) | 2012-10-12 | 2019-11-12 | Spirogen Sarl | Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation |
| ES2649990T3 (es) | 2012-10-12 | 2018-01-16 | Medimmune Limited | Conjugados de anticuerpos anti-CD22-pirrolobenzodiazepinas |
| CN110256469B (zh) | 2012-10-12 | 2022-05-17 | 麦迪穆有限责任公司 | 吡咯并苯并二氮杂卓及其结合物 |
| US10695433B2 (en) | 2012-10-12 | 2020-06-30 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
| GB201317981D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
| GB201317982D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
| WO2015052534A1 (en) | 2013-10-11 | 2015-04-16 | Spirogen Sàrl | Pyrrolobenzodiazepine-antibody conjugates |
| WO2015052535A1 (en) | 2013-10-11 | 2015-04-16 | Spirogen Sàrl | Pyrrolobenzodiazepine-antibody conjugates |
| WO2015052532A1 (en) | 2013-10-11 | 2015-04-16 | Spirogen Sàrl | Pyrrolobenzodiazepine-antibody conjugates |
| GB201416112D0 (en) | 2014-09-12 | 2014-10-29 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
| CA2968447A1 (en) | 2014-11-25 | 2016-06-02 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates and their use to treat neoplasms |
| GB201506402D0 (en) | 2015-04-15 | 2015-05-27 | Berkel Patricius H C Van And Howard Philip W | Site-specific antibody-drug conjugates |
| GB201506411D0 (en) | 2015-04-15 | 2015-05-27 | Bergenbio As | Humanized anti-axl antibodies |
| ITUB20152779A1 (it) * | 2015-08-03 | 2017-02-03 | Procos Spa | Processo per la sintesi di 4-cheto prolina protetta |
| GB201601431D0 (en) | 2016-01-26 | 2016-03-09 | Medimmune Ltd | Pyrrolobenzodiazepines |
| GB201602359D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| GB201602356D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| GB201607478D0 (en) | 2016-04-29 | 2016-06-15 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| GB201617466D0 (en) | 2016-10-14 | 2016-11-30 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
| AU2018217926B2 (en) | 2017-02-08 | 2019-10-03 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates |
| GB201702031D0 (en) | 2017-02-08 | 2017-03-22 | Medlmmune Ltd | Pyrrolobenzodiazepine-antibody conjugates |
| JP2020517609A (ja) | 2017-04-18 | 2020-06-18 | メディミューン リミテッド | ピロロベンゾジアゼピン複合体 |
| EP3612234B1 (en) | 2017-04-20 | 2024-03-13 | ADC Therapeutics SA | Combination therapy with an anti-axl antibody-drug conjugate |
| US11318211B2 (en) | 2017-06-14 | 2022-05-03 | Adc Therapeutics Sa | Dosage regimes for the administration of an anti-CD19 ADC |
| SI3668874T1 (sl) | 2017-08-18 | 2022-04-29 | Medimmune Limited | Pirolobenzodiazepinski konjugati |
| GB201803342D0 (en) | 2018-03-01 | 2018-04-18 | Medimmune Ltd | Methods |
| GB201806022D0 (en) | 2018-04-12 | 2018-05-30 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4296113A (en) | 1980-01-14 | 1981-10-20 | E. R. Squibb & Sons, Inc. | Mercaptoacyl derivatives of keto substituted proline and pipecolic acid |
| US4470972A (en) | 1981-04-28 | 1984-09-11 | Schering Corporation | 7-Carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids |
| DD283626A5 (de) * | 1989-03-30 | 1990-10-17 | Sandoz Ag,Ch | Verfahren zur herstellung von 7-(n-(1-(s)-carboethoxy-3-phenylpropyl-(s)-alanyl)-1,4-dithia-7-azaspiro(4,4)nonan 8(s)-carbonsaeure |
| DE19524339A1 (de) | 1995-07-04 | 1997-01-09 | Degussa | Verfahren zur Herstellung von N-substituierten 4-Ketoprolin-Derivaten |
| EP0915088B1 (en) * | 1997-10-31 | 2002-09-18 | F. Hoffmann-La Roche Ag | D-Proline derivatives |
| KR100286874B1 (ko) * | 1998-03-04 | 2001-04-16 | 성재갑 | 보호된 4-아미노메틸-피롤리딘-3-온의 제조방법 |
-
2004
- 2004-03-03 DE DE102004010943A patent/DE102004010943A1/de not_active Withdrawn
-
2005
- 2005-02-19 EP EP05707534A patent/EP1720832B1/en active Active
- 2005-02-19 CN CN200580006692XA patent/CN1926102B/zh active Active
- 2005-02-19 JP JP2007501160A patent/JP4728317B2/ja active Active
- 2005-02-19 CA CA2557017A patent/CA2557017C/en active Active
- 2005-02-19 PT PT57075343T patent/PT1720832E/pt unknown
- 2005-02-19 US US10/591,340 patent/US8618310B2/en active Active
- 2005-02-19 WO PCT/EP2005/001750 patent/WO2005095340A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005095340A1 (en) | 2005-10-13 |
| JP4728317B2 (ja) | 2011-07-20 |
| US8618310B2 (en) | 2013-12-31 |
| EP1720832B1 (en) | 2012-12-05 |
| US20070185336A1 (en) | 2007-08-09 |
| CA2557017A1 (en) | 2005-10-13 |
| CA2557017C (en) | 2012-10-02 |
| CN1926102A (zh) | 2007-03-07 |
| CN1926102B (zh) | 2011-01-05 |
| EP1720832A1 (en) | 2006-11-15 |
| DE102004010943A1 (de) | 2005-09-29 |
| JP2007526265A (ja) | 2007-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1720832E (pt) | Processo de preparação de derivados de 4-cetoprolina n-protegidos | |
| IL183568A (en) | Process for making 7,8-dihydro-5 h-patridine-6-onh | |
| IL178233A0 (en) | Process for producing 5-hydroxy-4-thiomethylpyrazole derivatives | |
| EP1828170A4 (en) | PROCESS FOR PREPARING VORICONAZOLE | |
| ZA200704202B (en) | Method for preparing n-phenylpyrazole-1-carboxamides | |
| IL172331A0 (en) | Processes for preparing 3-benzazepines | |
| IL215686A (en) | A process for making pure enzymes | |
| IL169879A0 (en) | Process for preparing pyrrolotriazine derivatives | |
| IL174029A0 (en) | Process for preparing 2-oxo-1-pyrrolidine derivatives | |
| IL183528A0 (en) | Process for preparing rosuvastatin | |
| IL182067A0 (en) | Process for preparing telmisartan | |
| HK1158628A1 (en) | Process for preparing dihydropteridinone derivatives | |
| IL178001A0 (en) | Process for preparing 5-methyl-2-furfural | |
| TWI372145B (en) | Process for preparing alkylanilides | |
| EP1767538A4 (en) | PROCESS FOR PREPARING A 1-OXACEPHALOSPORIN-7ALPHA-METHOXY-3-CHLOROMETHYL DERIVATIVE | |
| PL2213654T3 (pl) | Sposób wytwarzania pochodnych 2-amino-5-bromobenzamidu | |
| IL179107A0 (en) | Method for preparing n-piperidino-1,5-diphenylpyrazole-3-carboxamide derivatives | |
| EP1751123A4 (en) | PROCESS FOR PREPARING IRBESARTAN | |
| HK1099298A1 (en) | Improved process for preparing rebamipide | |
| HK1081528A1 (en) | Process for preparing tcd-alcohol dm | |
| SG137677A1 (en) | Improved process for preparing polyalkenylsuccinimides | |
| IL185872A0 (en) | Process for preparing levetiracetam | |
| IL175966A0 (en) | Process for preparing aripiprazole | |
| IL178069A0 (en) | Process for preparing n-aryl-piperazine derivatives | |
| GB0416694D0 (en) | Process for preparing microcrystals |